The Clinical Guidelines Committee of the American College of Physicians has published new best practice advice for screening average-risk women for cervical cancer.
The available HPV vaccines could prevent most cases of cervical intraepithelial neoplasia and adenocarcinoma in situ, according to an HPV genotype study.
The US introduction of a vaccine to prevent cervical cancer in 2006 has reduced infections of HPV by more than half among girls and young women, US health officials said on Wednesday.
